doi:10.3969/j.issn.1004-583X.2021.07.017

Abstract

CLC Number:

Add to citation manager EndNote|Ris|BibTeX

URL: https://huicui.hebmu.edu.cn/EN/10.3969/j.issn.1004-583X.2021.07.017

https://huicui.hebmu.edu.cn/EN/Y2021/V36/I7/655

References 28

[1]	Godoy LC, Rao V, Farkouh ME. Coronary revascularization of patients with diabetes mellitus in the setting of acute coronary syndromes[J]. Circulation, 2019,140(15):1233-1235. doi: 10.1161/CIRCULATIONAHA.119.040683 URL
[2]	Benjamin EJ, Virani SS, Callaway CW, et al. Heart disease and stroke statistics-2018 update:A report from the American Heart Association[J]. Circulation, 2018,137(12):e67-e492.
[3]	Paneni F, Beckman JA, Creager MA, et al. Diabetes and vascular disease: Pathophysiology, clinical consequences, and medical therapy: Part I[J]. Eur Heart J, 2013,34(31):2436-2443. doi: 10.1093/eurheartj/eht149 URL
[4]	Onat A, Dönmez I, Karadeniz Y, et al. Type-2 diabetes and coronary heart disease: Common physiopathology, viewed from autoimmunity[J]. Expert Rev Cardiovasc Ther, 2014,12(6):667-679. doi: 10.1586/14779072.2014.910114 URL
[5]	Wong GW, Wang J, Hug C, et al. A family of Acrp30/adiponectin structural and functional paralogs[J]. Proc Natl Acad Sci U S A, 2004,101:10302-10307. doi: 10.1073/pnas.0403760101 URL
[6]	Seldin MM, Tan SY, Wong GW. Metabolic function of the CTRP family of hormones[J]. Rev Endocr Metab Disord, 2014,15(2):111-123. doi: 10.1007/s11154-013-9255-7 URL
[7]	Wei Z, Peterson JM, Wong GW. Metabolic regulation by C1q/TNF-related protein-13 (CTRP13): Activation of AMP-activated protein kinase and suppression of fatty acid-induced JNK signaling[J]. J Biol Chem, 2011,286(18):15652-15665. doi: 10.1074/jbc.M110.201087 URL
[8]	Wong GW, Krawczyk SA, Kitidis-Mitrokostas C, et al. Identification and characterization of CTRP9, a novel secreted glycoprotein, from adipose tissue that reduces serum glucose in mice and forms heterotrimers with adiponectin[J]. FASEB J, 2009,23(1):241-258. doi: 10.1096/fsb2.v23.1 URL
[9]	Schäfflfler A, Buechler C. CTRP family:Linking immunity to metabolism[J]. Trends Endocrinol Metab, 2012,23(4):194-204. doi: 10.1016/j.tem.2011.12.003 URL
[10]	Byerly MS, Swanson R, Wei Z, et al. A central role for C1q/TNF-related protein 13(CTRP13) in modulating food intake and body weight[J]. PLoS One, 2013,8(4):e62862-e62869. doi: 10.1371/journal.pone.0062862 URL
[11]	An K, Starkweather A, Sturgill J, et al. Association of CTRP13 with liver enzymes and cognitive symptoms in nonalcoholic fatty liver disease[J]. Nurs Res, 2019,68(1):29-38. doi: 10.1097/NNR.0000000000000319 URL
[12]	Fadaei R, Moradi N, Baratchian M, et al. Association of C1q/TNF-related protein-3 (CTRP3) and CTRP13 serum levels with coronary artery disease in subjects with and without type 2 diabetes mellitus[J]. PLoS One, 2016,11(12):e0168773-e0168786. doi: 10.1371/journal.pone.0168773 URL
[13]	Wang C, Xu W, Liang M, et al. CTRP13 inhibits atherosclerosis via autophagy-lysosome-dependent degradation of CD36[J]. FASEB J, 2019,33(2):2290-2300. doi: 10.1096/fsb2.v33.2 URL
[14]	Zheng Q, Yuan Y, Yi W, et al. C1q/TNF-related proteins, a family of novel adipokines, induce vascular relaxation through the adiponectin receptor-1/AMPK/eNOS/nitric oxide signaling pathway[J]. Arterioscler Thromb Vasc Biol, 2011,31(11):2616-2623. doi: 10.1161/ATVBAHA.111.231050 URL
[15]	Tabas I, Bornfeldt KE. Macrophage phenotype and function in different stages of atherosclerosis[J]. Circ Res, 2016,118(4):653-667. doi: 10.1161/CIRCRESAHA.115.306256 pmid: 26892964
[16]	Volobueva A, Zhang DW, Grechko AV, et al. Foam cell formation and cholesterol trafficking and metabolism disturbances in atherosclerosis[J]. Cor Vasa, 2019,61(1):48-55. doi: 10.1016/j.crvasa.2018.06.006 URL
[17]	Ou H, Liu C, Feng W, et al. Role of AMPK in atherosclerosis via autophagy regulation[J]. Sci China Life Sci, 2018,61(10):1212-1221. doi: 10.1007/s11427-017-9240-2 URL
[18]	Afrookhteh A, Emamgholipour S, Alipoor B, et al. The circulating levels of complement-C1q/TNF-related protein 13 (CTRP13) in patients with type 2 diabetes and its association with insulin resistance[J]. Clin Lab, 2017,63(2):327-333. doi: 10.7754/Clin.Lab.2016.160609 pmid: 28182339
[19]	Shanaki M, Fadaei R, Nariman M, et al. The circulating CTRP13 in type 2 diabetes and non-alcoholic fatty liver patients[J]. PLoS One, 2016,11(12):e0168082-e0168092. doi: 10.1371/journal.pone.0168082 URL
[20]	Kobayashi J. Which is the best predictor for the development of atherosclerosis among circulating lipoprotein lipase, hepatic lipase, and endothelial lipase?[J]. J Atheroscler Thromb, 2019,26(9):758-759. doi: 10.5551/jat.ED108 pmid: 30814386
[21]	Radulovi'c S, Gottschalk B, Hörl G, et al. Endothelial lipase increases eNOS activating capacity of high-density lipoprotein[J]. Biochim Biophys Acta Mol Cell Biol Lipids, 2020,1865(4):158612-158623.
[22]	Bai B, Ban B, Liu Z, et al. Circulating c1q complement/TNF-related protein (CTRP) 1, CTRP9, CTRP12 and CTRP13 concentrations in type 2 diabetes mellitus: In vivo regulation by glucose[J]. PLoS One, 2017,12(2):e0172271-e0172282. doi: 10.1371/journal.pone.0172271 URL
[23]	Strauss HW, Nakahara T, Narula N, et al. Vascular calcification:The evolving relationship of vascular calcification to major acute coronary events[J]. J Nucl Med, 2019,60(9):1207-1212. doi: 10.2967/jnumed.119.230276 URL
[24]	Li Y, Wang W, Chao Y, et al. CTRP13 attenuates vascular calcification by regulating Runx2[J]. FASEB J, 2019,33(8):9627-9637. doi: 10.1096/fsb2.v33.8 URL
[25]	Shanaki M, Moradi N, Fadaei R, et al. Lower circulating levels of CTRP12 and CTRP13 in polycystic ovarian syndrome: Irrespective of obesity[J]. PLoS One, 2018,13(12):e0208059-e0208070. doi: 10.1371/journal.pone.0208059 URL
[26]	Koh KK. Role of adiponectin: important or null?[J]. J Am Coll Cardiol, 2017,69(11):1518-1524.
[27]	Xu W, Tian M, Zhou Y. The relationship between insulin resistance, adiponectin and C-reactive protein and vascular endothelial injury in diabetic patients with coronary heart disease[J]. Exp Ther Med, 2018,16(3):2022-2026.
[28]	Wang C, Chao Y, Xu W, et al. CTRP13 preserves endothelial function by targeting GTP cyclohydrolase 1 in diabetes[J]. Diabetes, 2020,69(1):99-111. doi: 10.2337/db19-0635 URL

RichHTML

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References 28

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	Huang Yuling, Zhang Xinyue, Rong Pingping, Yang Wenqi, Cao Xinying, Xing Cainai, Wang Zhijun, Liu Ning. Correlation analysis of Non-HDL-C/HDL-C and NHR with the severity of coronary artery disease [J]. Clinical Focus, 2024, 39(2): 115-120.
[2]	. [J]. Clinical Focus, 2024, 39(1): 80-83.
[3]	Wang Jiaqi, Xie Yuetao, Gao Man, Song Xuelian, Zhang Feifei, Dang Yi, Qi Xiaoyong. Treatment of variant angina pectoris guided by the optical coherence tomography: A case report and literature review [J]. Clinical Focus, 2023, 38(10): 917-921.
[4]	Yang Changlin, Cao Shufeng, Qiao Lian, Zhao Huimin. Type I Kounis syndrome caused by drug allergy: A case report [J]. Clinical Focus, 2023, 38(10): 922-925.
[5]	Wei Yuhan, Zhao Yanan, Zhang Guibin, Wu Yuqing, Dong Bohua, Hu Jiayuan, Yang Wenqi. Correlation analysis of monocyte-to-high density lipoprotein cholesterol ratio, red cell distribution width, and uric acid with the severity of coronary artery disease in patients with coronary heart disease [J]. Clinical Focus, 2023, 38(9): 796-801.
[6]	Li Hua, Chen Jianjun, Wei Jitao, Zhang Qi. Correlation between serum cystatin C level and nonobstructive coronary artery disease [J]. Clinical Focus, 2023, 38(9): 802-805.
[7]	Zhang Shangshi, Zhu Hongyan, Li Nan, Chen Yingxi. Correlation between coronary artery lesion and insulin resistance in patients with coronary heart disease combined with type 2 diabetes mellitus [J]. Clinical Focus, 2023, 38(1): 46-49.
[8]	Yi Xin, Liu Canzhang, Liu Qiang, Wang Cong, Gao Teng, Yan Jie. Effects of anxiety and depression on the composition and properties of coronary plaque in patients with coronary heart disease [J]. Clinical Focus, 2023, 38(1): 50-54.
[9]	Wang Yajie, Li Jianming, Liu Jingjing, Lu Yujie, Lin Wenhua. Predictor analysis of abnormal coronary flow reserve in women with non-obstructive coronary artery disease [J]. Clinical Focus, 2022, 37(9): 791-795.
[10]	Zhu Jun, Liu Yue, Chen Shuxia, Wang Xian, Zheng Luyan, Gu Jian. Predictive value of ApoB/ApoA1 ratio on the extent of coronary artery disease in patients with unstable angina pectoris [J]. Clinical Focus, 2022, 37(5): 422-426.
[11]	Wang Yajie, Lin Wenhua, Jing Rui, Liu Jingjing, Lu Yujie. The relationship between serum homocysteine levels and SYNTAX score in patients with non-ST-segment elevation myocardial infarction [J]. Clinical Focus, 2022, 37(4): 325-328.
[12]	Li Jianqin, Sheng Yueyue, Zhou Yinmin, Shi Weiqing, Yang Xingchen. Safety of clopidogrel combined with statins on acute coronary syndrome in patients based on metabolic pathways by different cytochrome P450 enzyme: a Meta analysis [J]. Clinical Focus, 2022, 37(2): 101-105.
[13]	Duan Liqin. Relationship between clinical features, peripheral microcirculatory and severity of coronary artery disease in patients with coronary heart disease [J]. Clinical Focus, 2022, 37(2): 119-123.
[14]	Chen Xi, Jiang Shan. Correlation analysis between neutrophil percentage-to-albumin ratio and degree of coronary artery stenosis [J]. Clinical Focus, 2022, 37(1): 26-29.
[15]	Zhao Weifeng, Ma Chunyu. Correlation between 25-(OH)D₃ and degree of coronary artery stenosis in patients with coronary heart disease [J]. Clinical Focus, 2021, 36(11): 981-985.